Personalized Medicine

Papers
(The TQCC of Personalized Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls39
The Evolution of Personalized Healthcare and the Pivotal Role of European Regions in its Implementation34
The United States 2020 Census Data: Implications for Precision Medicine and the Research Landscape20
Elevated Expression of ASF1B Correlates with Poor Prognosis in Human Lung Adenocarcinoma18
Pharmacogenomic Considerations for Repurposing of Dexamethasone as a Potential Drug Against SARS-CoV-2 Infection15
Gout Prevalence in the Hmong: A Prime Example of Health Disparity and the Role of Community-Based Genetic Research13
Artificial Intelligence in Healthcare: a Primer for Medical Education in Radiomics13
Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: a scoping review12
MiR-452-5p Mediates the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells Via Targeting COLEC1011
Clinician Perspectives on Communication and Implementation Challenges in Precision Oncology10
The Frequency of Major CYP2C19 Genetic Polymorphisms in Women of Asian, Native Hawaiian and Pacific Islander Subgroups10
Creating Accessible Spanish Language Materials for Clinical Sequencing Evidence-Generating Research Consortium Genomic Projects: Challenges and Lessons Learned10
LncRNA ZFAS1, as a Poor Prognostic Indicator, Promotes Cell Proliferation and Epithelial–Mesenchymal Transition in Endometrial Carcinoma9
Stem Cells as Therapeutic Targets in Colorectal Cancer9
Mini-Gut Feelings: Perspectives of People with Cystic Fibrosis on the Ethics and Governance of Organoid Biobanking9
miR-516a-3P, a Potential Circulating Biomarker in Hepatocellular Carcinoma, Correlated with rs738409 Polymorphism in PNPLA39
Recommendations to Researchers for Aiding in Increasing American Indian Representation in Genetic Research and Personalized Medicine9
Intelligent Health System for the Investigation of Consenting COVID-19 Patients and Precision Medicine8
Concentration and Integrity Indexes of Urine Cell-Free DNA as Promising Biomarkers for Early Lung Cancer Diagnosis7
Correlation of miR-600 with WT1 Expression and its Potential Clinical Significance in Breast Cancer6
The Role of miR-101 in Esophageal and Gastric Cancer6
Healthcare Professionals’ Knowledge, Attitudes and Future Expectations Towards Personalized Medicine6
An International Genomics Health Workforce Education Priorities Assessment6
MiR-455-5p Serves as a Biomarker of Atherosclerosis and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration6
Expanded Carrier Screening in Flanders (Belgium): An Online Survey on the Perspectives of Nonpregnant Reproductive-Aged Women6
Family-Level Impact of Genetic Testing: Integrating Health Economics and Ethical, Legal, and Social Implications6
Targeting Molecular Alterations in Non-Small-Cell Lung Cancer: What’s Next?6
Clinical Significance of Serum miR-101-3p Expression in Patients with Neonatal Sepsis6
Guanylyl Cyclase C as a Diagnostic and Therapeutic Target in Colorectal Cancer5
Views on Genomic Research Result Delivery Methods and Informed Consent: A Review5
Cost–effectiveness of Genetic-Based Screening Strategies for Maturity-Onset Diabetes of the Young5
Alignment of health plan coverage policies for somatic multigene panel testing with clinical guidelines in select solid tumors5
Prioritizing Pharmacogenomics Implementation Initiatives: A Survey of Healthcare Professionals5
Defining the Role of Pharmacists in Medication-Related Genetic Counseling5
Attitudes of Costa Rican Individuals Towards Donation of Personal Genetic Data for Research5
The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites5
Sino-European Science and Technology Collaboration on Personalized Medicine: Overview, Trends and Future Perspectives5
Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine5
Budget Impact and Transferability of Cost–effectiveness of DPYD Testing in Metastatic Breast Cancer in Three Health Systems4
Long Noncoding RNA Polymorphisms and Hepatocellular Carcinoma and Pancreatic Cancer Risk4
The Integration of Personalized Medicine Into Health Systems: Progress and a Path Forward4
PON1 Polymorphisms Can Predict Generalized Anxiety and Depressed Mood in Patients with Multiple Chemical Sensitivity4
How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests?4
Association Study of Genetic Polymorphisms in GABRD with Treatment Response and Dose in Methadone Maintenance Treatment4
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension4
SKA3 , negatively regulated by miR-128-3p , promotes the progression of non-small-cell lung cancer4
Recent Advances in Personalized Cancer Immunotherapy with Immune Checkpoint Inhibitors, T Cells and Vaccines4
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis4
Role of precision nutrition in improving military performance4
Association of PON-1 polymorphism with susceptibility to and severity of ischemic stroke in the Chinese population4
Personalized Therapy: Can it Tame the COVID-19 Monster?4
0.034371137619019